Prevalence of Chronic Backpain after COVID-19 Astra Zeneca and Pfizer/BioNTech Vaccines in Sultanate of Oman: A Survey-based Study-Reference-Cited by-同舟云学术

Prevalence of Chronic Backpain after COVID-19 Astra Zeneca and Pfizer/BioNTech Vaccines in Sultanate of Oman: A Survey-based Study

Published:2023-09-30 Issue:3 Volume:16 Page:1725-1731
ISSN:2456-2610
Container-title:Biomedical and Pharmacology Journal
language:en
Short-container-title:Biomed. Pharmacol. J.

Author:

A. Hamad Nasir¹^ORCID,Eltayeb Lienda Bashier²^ORCID,Vasudevan Senthilvel³^ORCID,Raj Priyanka⁴^ORCID

Affiliation:

1. 1Department of Biochemistry, College of Medicine and Health Sciences , Al-Neelain University, Sudan. National University, Oman.

2. 2Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University- Al-Kharj, Riyadh, KSA.

3. 3Department of Public Health and Biostatistics, College of Medicine and Health Sciences, National University, Oman.

4. 4Department of Community Medicine, Sri Venkateshwara Medical College, India.

Abstract

Introduction: Covid-19 vaccine is known to cause a variety of side effects. Low back pain has been reported to be associated with at least one of the COVID-19 vaccines. Objectives: The current study investigated the prevalence of chronic back pain in individuals vaccinated with AstraZeneca and Pfizer in Sultanate of Oman. Methods: This cross-sectional observational survey-based study was conducted among COVID-19 AstraZeneca and Pfizer/BioNTech vaccinated individuals in Sultanate of Oman. Two hundred participants were involved in the study. Chi square was used to analyse the association between categorical data. Data were analysed using SPSS (29th release). Results: The prevalence of back pain among individuals vaccinated with AstraZeneca and Pfizer, was 36%. Females were more commonly affected by the back pain, especially in the 4th decade of life. Conclusion: AstraZeneca and Pfizer is be associated with back pain, especially in females. Possible explanations require further investigations.

Publisher

Oriental Scientific Publishing Company

Subject

Pharmacology

Reference23 articles.

1. 1. Lienda Bashier Eltayeb. An update about Coronaviruses with Emphasis on Newly Emerged COVID 19. J Biochem Tech (2020) 11 (3): 14-20 ISSN: 0974-2328.

2. 2. COVID-19 mRNA Pfizer- BioNTech vaccine analysis print. Medicines and healthcare products regulatory agency (MHRA) COVID-19 mRNA Pfizer-BioNTech vaccine analysis print. https://www.gov.uk/ government.

3. 3. Pratibha Anand, Vincent P. Stahel; Review the safety of Covid-19 mRNA vaccines. Patient Saf Surg. 2021; 15: 20.

4. 4. Pratibha Anand, Vincent P. Stahel; Review the safety of Covid-19 mRNA vaccines. Patient Saf Surg. 2021; 15: 20.

5. 5. https://www.pfizer.com